CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Sequenom, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Sequenom, Inc.
3595 John Hopkins Ct
Phone: (858) 202-9000p:858 202-9000 SAN DIEGO, CA  92121-1121  United States Fax: (858) 202-9001f:858 202-9001
This company was Merged or Acquired on 9/7/2016.
This company ceased filing statements with the SEC on 9/23/2016.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
Sequenom, Inc. is a life sciences company. The Company serves patients and physicians by providing early patient management information. The Company operates through Sequenom Laboratories segment. It conducts its business as a molecular diagnostics clinical laboratory located in San Diego, California and Raleigh-Durham, North Carolina. Its testing focus is on prenatal health that includes molecular-based laboratory developed tests (LDTs). The Company's diagnostic services are provided through its subsidiary, Sequenom Center for Molecular Medicine LLC (SCMM), doing business as Sequenom Laboratories. Sequenom Laboratories develops and validates its tests to be used as a testing service to physicians. Sequenom Laboratories is focused on developing and offering a menu of tests for prenatal continuum of care. The Sequenom Laboratories' test offerings in the prenatal market include MaterniT21 PLUS LDT, HerediT CF test, SensiGene RhD test, VisibiliT test and Test Send-out Agreements.
(Source: 10-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/201612/31/2015YesYes--Yes

Industries
SIC Code Description
3829 Measuring and controlling devices, not elsewhere classified
3845 Electromedical and electrotherapeutic apparatus
3826 Laboratory analytical instruments

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board Kenneth F.Buechler 61 4/1/2015 12/16/2009
President, Chief Executive Officer, Director Dirkvan den Boom 46 12/10/2015 8/1/2010
Chief Financial Officer, Senior Vice President Carolyn D.Beaver 57 3/10/2015 6/26/2012
8 additional Officers and Directors records available in full report.

Business Names
Business Name
Gemini Genomics, Ltd.
Sequenom Biosciences (India) Pvt. Ltd
Sequenom Center for Molecular Medicine, LLC
Sequenom Laboratories

General Information
Stock Exchange: NASD
Federal Tax Id: 770365889
Fax Number: (858) 202-9001
Email Address: mhenshaw@sequenom.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023